Evaluation of abnormal liver function tests

Postgraduate Medical Journal

Volumn 79, Issue 932, 2003, Pages 307-312

  Limdi, Jimmy K ^a   Hyde, G M ^b  

^a TAMESIDE GENERAL HOSPITAL   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; SERUM ALBUMIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; AUTOIMMUNE HEPATITIS; BILE FLOW; FATTY LIVER; HEMOCHROMATOSIS; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; LIVER DISEASE; LIVER FUNCTION; LIVER FUNCTION TEST; PATHOPHYSIOLOGY; PROTHROMBIN TIME; REVIEW; WILSON DISEASE;

ALKALINE PHOSPHATASE; BILIRUBIN; BLOOD COAGULATION TESTS; GAMMA-GLUTAMYLTRANSFERASE; HEMOCHROMATOSIS; HEPATITIS, AUTOIMMUNE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; STEATITIS; TRANSAMINASES;

EID: 0037668277     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.932.307     Document Type: Review

References (19)

1. Friedman LS, Martin P, Munroz SJ. Liver function tests and the objective evaluation of the patient with liver disease. In: Zakim D, Boyer TD, ed. Hepatology: a textbook of liver disease. Vol 1. Philadelphia, WB Saunders, 1996:791-833.
2. Pratt DS, Kaplan MM. Laboratory tests. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. 8th Ed. Vol 1. Philadelphia: Lippencott-Raven, 1999:205-44.
3. Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's gastrointestinal and liver disease. 7th Ed. 2002:1227-39, 1310-11.
4. Pratt DS, Kaplan MM. Evaluation of abnormal liver enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-71.
5. Cohen JA, Kaplan MM. The SGOT/SGPT ratio-an indicator of alcoholic liver disease. Dig Dis Sci 1979;24:835-8.
6. Minuk G. Canadian Association of Gastroenterology Practice Guidelines: evaluation of abnormal liver enzyme tests. Can J Gastroenterol 1998;12(6):417-21.
7. Schiff ER, de Medina M, Kahn RS. New perspectives in the diagnosis of hepatitis C. Semin Liver Dis 1999;suppl 1:3-15.
8. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1-12.
9. Diehl AM, Goadman Z, Ishak KG. Alcohol like liver disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-62.
10. Bacon BR, Farahvash MJ, Janney CG, et al. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9.
11. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine transferase: potential value in differentiating non-alcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999;94:1018-22.
12. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
13. Eriksson S, Eriksson KF, Bondesson L.Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986;220:83-8.
14. Powell LW, George DK, McDonnell SM, et al. Diagnosis of haemochromatosis. Ann Intern Med 1998;129:925-31.
15. Guyader D, Jacquelinet C, Moirand R, et al. Non invasive prediction of fibrosis in C282Y homozygous haemochromatosis. Gastroenterology 1998;115:929-36.
16. Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be caused by occult coeliac disease. Hepatology 1999;29:654-7.
17. Goldberg DM, Martin JV. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion 1975;12:232-46.
18. Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet 1971;ii:376-7.
19. Bloom S, ed. Abnormal liver function test in an asymptomatic patient. Practical gastroenterology. 1st Ed. UK: Martin Dunitz, 2002:503-6.